Our preliminary results show neither a benefit nor any harm from intervention in both anatomic and visual outcomes. Our results support conducting additional studies to evaluate the effect of intravitreal bevacizumab on postoperative PVR.
No takes yet. Share an insight, caveat, or question.
Soheilian et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: